DA32 Life Science Tech Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DALS research report →
Price Chart
About the company
Currently, DA32 Life Science Tech Acquisition Corp. does not engage in substantial operational activities. Its core objective is to finalize a business combination, which may involve a merger, an exchange of capital stock, an acquisition of assets or stock, or a corporate reorganization with other companies.
- CEO
- Steven Kafka
- IPO
- 2021
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on DALS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $11.22
- 52W Low
- $9.68
- 50D MA
- $10.27
- 200D MA
- $10.09
- Beta
- 0.00
- RSI (14)
- 64
- Avg Volume
- 29.06K
No earnings-call transcripts are available for DALS yet.
- Free Float
- 0.0%
- Shares Outstanding
- 25.65M
- Float Shares
- 0
of shares held by institutions
50 13F filers
Buy/sell ratio 0.56. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 28, 23 | CRANDELL KEITH | other | 1,600,000 |
| Jul 28, 23 | ARCH Venture Fund XI, L.P. | other | 1,600,000 |
| Jul 28, 23 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | other | 1,600,000 |
| Aug 5, 21 | Section 32 Fund 3, LP | sell | 701,250 |
| Aug 5, 21 | Section 32 Fund 3, LP | sell | 30,000 |
| Aug 5, 21 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | sell | 701,250 |
| Aug 5, 21 | Wolfe Chris | sell | 18,750 |
| Aug 5, 21 | CRANDELL KEITH | sell | 701,250 |
| Aug 5, 21 | ARCH Venture Fund XI, L.P. | other | 701,250 |
| Aug 5, 21 | DA32 Sponsor LLC | other | 701,250 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DALS coverage
Recent articles, reports, and earnings notes.
No research on DALS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DALS report →Deerfield Management Company, L.P.
gurufocus.com · Aug 1
DA32 Life Science Tech Acquisition Corp. Announces Redemption of Shares
businesswire.com · Jul 21
DA32 Life Science Tech Acquisition Corp., Sponsored by Deerfield, Arch Venture Partners and Section 32, Announces Pricing of $200 Million Initial Public Offering
businesswire.com · Jul 27
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.